Sign in

You're signed outSign in or to get full access.

Laura Posadas

Director at Koppers Holdings
Board

About Laura Posadas

Independent director at Koppers Holdings Inc. (NYSE: KOP) since November 5, 2025; the Board increased its size from eight to nine and elected her the same day . The Board determined she is independent under NYSE listing standards and Koppers’ Corporate Governance Guidelines, with no reportable related-party transactions; she will stand for election at the 2026 Annual Meeting . Posadas is a specialty chemicals operator with 20+ years of global leadership experience; she holds a chemistry degree from the University of Delaware . Prior roles include CEO of Canlak Coatings (Oct 2024–present), CCO of Matrix Adhesives Group (Jan 2023–Oct 2024), and Regional President, Americas of Castrol for BP (Dec 2019–Dec 2022) .

Past Roles

OrganizationRoleTenureNotes
Canlak Coatings Inc.Chief Executive OfficerOct 2024–presentPortfolio company of SK Capital; wood coating systems
Matrix Adhesives GroupChief Commercial OfficerJan 2023–Oct 2024Advanced adhesives and sealants provider
BP p.l.c. (Castrol)Regional President, AmericasDec 2019–Dec 2022Global integrated energy company; Castrol brand

External Roles

OrganizationRoleTenure/StatusFocus/Impact
CoqualDirector; Chair of Advisory ArmCurrentGlobal think tank on workplace/leadership redesign

Board Governance

  • Appointment and board size: Elected November 5, 2025; Board expanded from 8 to 9 .
  • Independence: Board determined she is an independent director under NYSE and company standards .
  • Committees: Not yet determined as of appointment .
  • Election timing: Will stand for shareholder election at Koppers’ 2026 Annual Meeting .
  • Conflicts/related party: No transactions reportable under Item 404(a) and no arrangements/understandings for her selection .
  • Attendance context: In 2024, cumulative Board and committee attendance was 100% (pre‑appointment; background on board engagement) .

Fixed Compensation

ComponentAmount/TermsApplicability/Notes
Annual cash retainer (non‑employee directors)$85,000Standard program referenced for Ms. Posadas’ compensation
Annual equity award (RSUs)$110,000Granted to new directors on election date; prorated if <12 months; shares determined by closing price; vests at earlier of 365 days or next AGM
Committee chair retainersAudit Chair: $20,000; Compensation Chair: $17,500 (effective 1/1/2025); Nominating & Corporate Governance Chair: $15,000 (effective 1/1/2025); Other committee chairs: $12,500Committees for Ms. Posadas TBD; amounts per latest program update
Meeting fees (excess meetings)$1,000 per board or committee meeting beyond six/yearStandard program
Non‑Executive Chair retainer$100,000Not applicable to Ms. Posadas unless serving in that role
Director deferral planCash and RSUs may be deferred into stock units; paid after board service endsAlignment mechanism; dividends credited as stock units
Stock ownership guidelines (directors)5x annual cash retainer; retain 75% of net shares until achievedApplies to non‑employee directors

Performance Compensation

Award TypePerformance Metric(s)WeightVesting / Notes
Director RSUsNone (time‑based only)N/AVest at earlier of 365 days or next annual meeting; accelerated on change in control

No performance‑conditioned director pay elements are disclosed in Koppers’ director compensation program .

Other Directorships & Interlocks

CategoryDetail
Current public company boardsNone disclosed in Koppers’ 8‑K and press release announcing her election
Non‑profit/other boardsCoqual (Director; chairs advisory arm)
Potential interlocks/conflictsCompany stated no Item 404(a) related‑party transactions with Ms. Posadas

Expertise & Qualifications

  • Specialty chemicals leadership (P&L, commercial, operations) across coatings, adhesives, lubricants; 20+ years’ global roles .
  • CEO experience and prior regional business leadership (Castrol/BP) .
  • Technical foundation: Chemistry degree, University of Delaware .
  • Governance experience via Coqual board and advisory leadership .

Equity Ownership

FilingEvent DateFiledTitle of SecurityAmount Beneficially OwnedOwnership Form
Form 3 (Initial Statement)11/05/202511/07/2025Common Stock0Direct (D)
  • Derivative securities: None reported on Form 3 .
  • Expected equity: New non‑employee directors receive a prorated RSU grant valued at $110,000 on election date, with shares determined by grant‑date closing price and vesting at earlier of 365 days or next AGM (number of shares not disclosed in filing) .
  • Director stock ownership guidelines: 5x annual cash retainer; 75% net‑shares retention until achieved .

Governance Assessment

  • Strengths: Independent; no related‑party transactions; relevant chemicals domain expertise; alignment mechanisms include standard RSU grants, director stock ownership guidelines, and ability to defer into stock units .
  • Policy safeguards: Koppers’ insider trading policy prohibits hedging, short sales, and pledging of company securities by directors, which supports alignment and mitigates risk .
  • Oversight/engagement: Board maintained strong 2024 attendance (100% cumulative), and operates five standing committees with independent membership requirements (context for expected engagement once Ms. Posadas’ committee assignments are made) .
  • Watch items: Committee assignments and attendance for Ms. Posadas not yet available (new appointment); initial beneficial ownership is zero pending standard RSU grant; monitor subsequent Form 4 filings and progress toward 5x ownership guideline .

RED FLAGS: None identified. Company explicitly disclosed no Item 404(a) related‑party transactions; independence affirmed; no hedging/pledging permitted under policy .